Page last updated: 2024-10-25

desipramine and Injuries, Spinal Cord

desipramine has been researched along with Injuries, Spinal Cord in 2 studies

Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, JE1
Liu, BP1
Park, JH1
Strittmatter, SM1
Rawlow, A1
King, RG1

Other Studies

2 other studies available for desipramine and Injuries, Spinal Cord

ArticleYear
Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
    Neuron, 2004, Oct-28, Volume: 44, Issue:3

    Topics: 5,7-Dihydroxytryptamine; Animals; Axons; Behavior, Animal; Blotting, Northern; Blotting, Southern; B

2004
The effects of desipramine (DMI) and alpha-2 adrenoceptor agonists on flexor reflex activity (FRA) in the spinalized and decerebrate rat.
    Journal of neural transmission. General section, 1991, Volume: 84, Issue:1-2

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Cordotomy; Decerebrate State; Desi

1991